Management tracks: Unity, Shield, Tusk

Anti-aging company Unity Biotechnology Inc. (San Francisco, Calif.) hired Bob Goeltz as CFO, Doug Rich as SVP of operations and Tamara Tompkins as general counsel. Goeltz will replace interim CFO John Smither, and Tompkins will replace Keith Klein. Goeltz was CFO at CytomX Therapeutics Inc. (NASDAQ:CTMX), Rich was SVP of operations at Kythera Biopharmaceuticals Inc., which Allergan plc (NYSE:AGN) acquired, and Tompkins was general counsel, operating partner and chief administrative officer at Khosla Ventures.

Metabolic company Shield Therapeutics plc (LSE:STX) said CFO Joanne Estell resigned. Karl Keegan will serve as interim CFO while the company seeks a replacement...